Health ❯ Healthcare ❯ Medical Research

Neurology

Alzheimer's Disease Dementia Parkinson's Disease Epilepsy Amyotrophic Lateral Sclerosis Stroke Migraine Treatment Multiple Sclerosis Biomarkers Dementia Awareness

Brockman Family Donates $110 Million to Houston Methodist, New Tower to Carry Their Name

The donation will seed a $100 million innovation fund to speed neuroscience research and AI-driven treatments.

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

Glucosamine Linked to Faster Progression and Higher Death Rates in Alzheimer’s Patients

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Study Identifies Switch That Halts Post‑Stroke Repair, Prolongs Recovery in Mice

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

Blood Test Detects Alzheimer’s Risk Years Before PET Scans

Meta-Analysis Finds No Link Between Hormonal Birth Control and Idiopathic Intracranial Hypertension

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

Dual Blood Markers Sharpen Alzheimer’s Diagnosis by Cutting False Positives

PrimeC Shows Safety and Potential Benefit in ALS Phase 2b as FDA Authorizes Phase 3

Blood Test Using p‑Tau217 Predicts Dementia Risk in Women Up to 25 Years Before Symptoms

Early Alzheimer’s Markers Identified in Peripheral Retina in Mouse Study

Blood ‘Clock’ Predicts Alzheimer’s Symptom Onset Within 3–4 Years

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds